Understanding Polydioxanone Suture Absorption Time and Strength
Share
Among the medical sutures available for veterinary surgery, polydioxanone occupies a distinct position. No other widely used absorbable material offers the same combination of extended tensile strength retention and predictable hydrolytic absorption over such a long timeline. For veterinary surgeons managing slow-healing tissues, high-tension closures, and procedures where the consequences of premature suture failure are serious, understanding exactly how PDS sutures behave after implantation is a clinical necessity.
This guide covers the chemistry behind polydioxanone, its absorption timeline, how its tensile strength evolves from implantation through complete absorption, the clinical situations where it delivers its most significant advantages, and how it compares to the other absorbable materials in a comprehensive veterinary surgical suture guide.
What Is Polydioxanone?
Polydioxanone is a synthetic polymer produced from the ring-opening polymerization of p-dioxanone monomer. The resulting material is formed into a monofilament suture strand. Unlike braided or twisted materials, the polydioxanone suture is a single continuous strand, which gives it the smooth surface and low capillarity properties that characterize all monofilament surgical sutures.
The key distinction of polydioxanone compared to other synthetic absorbable polymers such as PGA and PGCL is the structure of its molecular chains. The ester-ether backbone of polydioxanone undergoes hydrolysis more slowly than the ester bonds in PGA or PGCL. This structural difference is the chemical basis for PDS sutures' much longer tensile retention and absorption timeline.
Degradation occurs exclusively through hydrolysis. Water molecules penetrate the suture and gradually cleave the molecular bonds, breaking the polymer into smaller fragments that are ultimately metabolized and excreted by the animal. Because this process is chemical rather than enzymatic, it is not significantly influenced by local infection, tissue inflammation, or individual variation in animal physiology. This predictability is one of the primary clinical advantages of PDS sutures in demanding surgical applications.
The ASSUFIL Monofilament from Gexfix International Corp. is the polydioxanone suture in the Assut Europe range, manufactured to ISO 13485 standards with full traceability and validated sterilization throughout production.
Polydioxanone Suture Absorption Time
The polydioxanone suture absorption time is 180 to 210 days from implantation. This is the longest absorption timeline among the synthetic absorbable sutures used in routine veterinary surgical practice, approximately two to three times longer than PGA and nearly twice the duration of PGCL.
This extended timeline reflects the slower hydrolytic breakdown of polydioxanone's molecular structure. The suture does not disappear rapidly from tissue but instead degrades in a gradual and controlled manner. During the early weeks after implantation, the physical structure of the suture remains largely intact. The suture retains both its monofilament form and a substantial proportion of its initial tensile strength during this period. Degradation then accelerates through the middle phase of absorption, with the remaining polymer fragments metabolized by surrounding tissue before complete absorption is achieved.
For veterinary surgeons planning procedures that involve slow-healing structures, the polydioxanone suture absorption time provides a practical framework for understanding how long the tissue layer will receive suture-generated mechanical support before being entirely reliant on its own collagen-based integrity.
Understanding how this timeline compares across different absorbable materials helps frame the clinical decision process. For a full side-by-side view, see Understanding How Absorbable Sutures Work and How Long They Last.
Tensile Strength Retention Over Time
The clinical utility of PDS sutures is best understood through how tensile strength changes from the point of implantation through complete absorption. Tensile strength is distinct from absorption time. A suture can retain meaningful mechanical support long before it has fully disappeared from the tissue, and the rate at which strength declines is the clinically relevant variable during the healing period.
PDS monofilament maintains approximately 70 to 80 percent of its initial tensile strength at four weeks after implantation. This means that at the point where most shorter-duration absorbable sutures have already lost the majority of their mechanical support, PDS sutures are still performing close to their original strength.
At six weeks, PDS sutures retain approximately 50 to 60 percent of initial tensile strength. At twelve weeks, meaningful tensile strength is still present, though declining. This progressive profile provides extended coverage through the full early and mid remodeling phase of healing in slow-healing structures, well past the period where faster-absorbing sutures would have already weakened significantly.
By contrast, PGA (ASSUFIL®) retains approximately 70 to 80 percent of initial strength in the first week and has lost the majority of its tensile support by four to six weeks. PGCL retains approximately 50 percent at two weeks and provides extended support to around 90 to 120 days, but still falls short of the sustained mechanical coverage that PDS delivers through the critical mid-healing phase of body wall and fascial repairs.
This difference in strength retention timeline is the core clinical reason for selecting PDS over shorter-duration absorbable sutures in high-demand surgical sites. For a comparison of how all absorbable materials perform across procedures, see Role of Absorbable Sutures in Veterinary Soft Tissue Surgery Healing.
Why the Strength Timeline Matters in Veterinary Tissue Healing
Wound healing in veterinary patients progresses through three overlapping phases. During the inflammatory phase in the first five days, the suture provides the entire mechanical support of the closure. During the proliferative phase from approximately day five to fourteen, fibroblasts begin producing collagen and the wound starts to develop native tensile strength. During the remodeling phase from week two through week eight and beyond, collagen matures and the tissue reaches progressively higher levels of its final mechanical integrity.
For most soft tissues such as the gastrointestinal wall, subcutaneous layers, and mucosal surfaces, the remodeling phase is sufficiently advanced by four to six weeks that a suture with the strength profile of PGA provides adequate coverage. For slower-healing structures such as the linea alba, external rectus sheath, fascia, and tendon-adjacent tissue, the remodeling timeline extends significantly beyond this. These tissues may not reach adequate native tensile strength until twelve to sixteen weeks or later.
Using a suture with a four to six week tensile retention window in a tissue that requires twelve weeks of mechanical support creates a period of unsupported healing during which wound dehiscence or hernia formation can occur. PDS sutures fill this gap by providing meaningful tensile support through twelve weeks and beyond, aligning the suture's mechanical performance with the healing timeline of these demanding tissue layers.
This principle is central to selecting the appropriate deep tissue suture for any procedure. For a detailed framework on matching suture material to tissue type and healing requirements, see How to Select the Best Deep Tissue Suture for Veterinary Surgery.
Clinical Applications of PDS Sutures in Veterinary Surgery
The extended tensile retention of PDS sutures defines the range of applications where they deliver their most significant clinical advantages.
Body wall and linea alba closure is the most common and important application of PDS in small animal surgery. The linea alba is the primary structural element of the ventral abdominal wall. It is under continuous mechanical load from intra-abdominal pressure during respiration and movement, and it heals slowly because it is composed largely of dense connective tissue with a relatively modest blood supply. Closure of the linea alba with a suture that loses tensile strength before adequate collagen maturation has occurred is one of the most preventable causes of post-operative ventral hernia formation. PDS provides the extended mechanical support this structure requires. Using size 2-0 for routine small animal body wall closure and size 0 for large breed dogs provides appropriate gauge coverage across patient categories.
Hernia repair similarly demands extended tensile support. Fascial defects closed under tension are subject to the same continuous mechanical load as the body wall and carry the same risk of failure if the suture's strength window is shorter than the tissue's remodeling timeline. PDS is the appropriate material for primary hernia repair closures in veterinary patients.
Tendon repair and tendon-adjacent soft tissue closures benefit from PDS's extended profile because tendons are among the slowest-healing structures in the veterinary patient. Full tensile recovery of tendon tissue can take months, and the suture used to approximate tendon edges or stabilize surrounding soft tissue must remain mechanically effective throughout this period.
Orthopedic soft tissue closures around bone implants and fracture repair sites benefit from PDS because the tissues involved heal slowly and are subject to the ongoing mechanical demands of limb loading during the recovery period.
Fascial closure in large animals including horses and cattle routinely uses PDS because the scale of the tissue and the mechanical demands at the closure site far exceed what shorter-duration sutures can support adequately.
The ASSUFIL® Monofilament PDS suture is available in the size range needed to cover all of these applications across species and patient sizes.
Handling Properties of PDS Sutures
As a monofilament, PDS sutures have a smooth surface that passes through tissue with minimal drag and presents no interstices where bacteria can colonize. These properties make PDS a good choice in potentially contaminated surgical environments, including abdominal procedures where gastrointestinal content exposure is a risk, and in orthopedic surgery where infection of the implant site is a serious concern.
The monofilament structure also means that PDS has a degree of memory, the tendency to retain the coiled shape of its packaging. This requires the surgeon to use additional throws when tying knots to achieve reliable knot security. The smooth surface of the monofilament reduces the friction between strands that would otherwise contribute to knot stability in a braided material. Experienced veterinary surgeons account for this characteristic by using four to five throws as standard practice when tying PDS sutures.
Despite the handling adjustment required, the benefits of the monofilament structure in terms of infection resistance and tissue passage quality are well established. For a full comparison of how monofilament handling differs from multifilament in clinical practice, see How Monofilament vs Multifilament Suture Performs in Veterinary Procedures.
Tissue Reaction and Biocompatibility
PDS sutures degrade through hydrolysis into byproducts that are metabolized and excreted without triggering significant enzymatic inflammation. The tissue reaction provoked by polydioxanone is minimal in most veterinary patients. Mild local tissue response in the immediate post-operative period is normal for any suture material and typically resolves as healing progresses.
Because PDS does not trigger enzymatic degradation pathways, the absorption timeline is not accelerated by local infection or tissue inflammation in the way that natural absorbable materials such as Chromic Catgut can be. This stability of the absorption timeline under variable tissue conditions is a meaningful clinical advantage in procedures where the healing environment may be unpredictable.
For a detailed overview of how different suture materials compare in terms of tissue reaction and biocompatibility, see How Veterinary Suture Material Impacts Surgical Outcomes in Animals.
How PDS Compares to Other Absorbable Sutures in a Surgical Suture Guide Context
Any comprehensive surgical suture guide for veterinary professionals should position each absorbable material according to its absorption timeline and tensile retention profile. The following comparison places PDS within the broader context of the absorbable sutures available in the Gexfix range.
PGA (ASSUFIL®) degrades over 60 to 90 days with strong early tensile retention of 70 to 80 percent in the first week. It is the appropriate choice for gastrointestinal surgery, subcutaneous closure, and general soft tissue procedures where mid-term support is adequate. It should not be used as a substitute for PDS in high-tension or slow-healing tissue layers.
PGCL is a monofilament absorbable suture with a 90 to 120 day absorption timeline. It retains approximately 50 percent of initial strength at two weeks and provides extended mid-term support that exceeds PGA. It is used when monofilament infection resistance is needed alongside extended absorption, such as in contaminated soft tissue closures. It does not match the tensile retention profile of PDS at four and twelve weeks.
ASSUCROM Chromic Catgut degrades enzymatically with tensile strength loss within 15 to 20 days from implantation and complete absorption over 90 to 120 days. It is appropriate for short-term mucosal closures and internal ligations. It is not appropriate for any application requiring multi-week tensile support.
PDS sutures with their 180 to 210 day polydioxanone suture absorption time and sustained strength retention through twelve weeks or beyond occupy the segment of the suture portfolio that none of the other absorbable materials can adequately replace for high-demand slow-healing applications.
For a broader overview of how each material is chosen based on procedure type and tissue layer, see Complete Guide to Choosing Veterinary Surgical Sutures for Your Practice.
FILBLOC® Barbed PDS for Advanced Closure Applications
For veterinary surgeons looking to combine the tensile advantages of polydioxanone with the efficiency of knotless closure, FILBLOC® Barbed Suture offers a PDS-based barbed monofilament option. The laser-cut barbs along the length of the strand anchor into tissue without requiring knots, distributing tension evenly across the full suture line rather than concentrating it at tied knot points.
This design is particularly useful in longer closures such as laparoscopic abdominal procedures, extended fascial repairs, and reconstructive surgeries where the knotless format reduces closure time without compromising the mechanical advantages of polydioxanone. The barbed structure eliminates the knot security challenge associated with standard PDS monofilament, making efficient placement more accessible without sacrificing the extended absorption profile that makes this material clinically valuable.
Conclusion
Polydioxanone suture absorption time of 180 to 210 days and sustained tensile strength retention through twelve weeks and beyond make PDS sutures the appropriate choice for veterinary surgical applications where slow-healing tissue, high mechanical demand, or extended structural support define the clinical requirements. Body wall closure, hernia repair, fascial closure, tendon-adjacent repairs, and large animal orthopedic soft tissue closures represent the core applications where PDS delivers a clinical advantage that shorter-duration absorbable materials cannot match.
Gexfix International Corp., in partnership with Assut Europe S.P.A., supplies ASSUFIL® PDS monofilament alongside a comprehensive range of medical sutures including ASSUFIL® PGA, PGCL, ASSUCROM® Chromic Catgut, ASSUNYL® Nylon, and FILBLOC® Barbed Sutures. With over 30 years of manufacturing expertise and ISO 13485-certified production standards, Gexfix supports veterinary practices with the reliable, clinically appropriate suture materials that consistent surgical outcomes require.
Explore the full veterinary suture range at Gexfix International Corp..
FAQs
Q. What is the polydioxanone suture absorption time in veterinary patients?
A. Polydioxanone sutures absorb completely over 180 to 210 days from implantation. This is the longest absorption timeline among synthetic absorbable medical sutures used in routine veterinary practice and is achieved through gradual hydrolytic degradation of the polymer chains in tissue.
Q. How long do PDS sutures retain tensile strength after implantation?
A. PDS sutures retain approximately 70 to 80 percent of initial tensile strength at four weeks and approximately 50 to 60 percent at six weeks. Meaningful mechanical support continues through twelve weeks and beyond, making them suitable for slow-healing structures such as body wall fascia and tendons.
Q. Why are PDS sutures preferred for body wall closure in veterinary surgery?
A. The linea alba and abdominal wall fascia heal slowly and bear continuous mechanical load during recovery. PDS sutures provide extended tensile support through the full remodeling period of these structures, reducing the risk of wound dehiscence or hernia formation that can occur if shorter-duration sutures are used.
Q. Can PDS sutures be used in contaminated wounds?
A. Yes. The monofilament structure of PDS resists bacterial colonization because it presents no interstices between braided strands where bacteria can harbor. This makes PDS sutures more appropriate than braided absorbable alternatives in potentially contaminated internal surgical environments.
Q. How does polydioxanone compare to PGA in terms of absorption and strength?
A. PGA absorbs in 60 to 90 days and retains most tensile strength in the first week before declining rapidly. PDS absorbs in 180 to 210 days and maintains 70 to 80 percent strength at four weeks. PGA suits fast-healing soft tissue layers while PDS is needed for slow-healing high-tension structures.